1-8 of 8
Joseph Rosenblatt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5)

Clinical Trials & Observations
Sattva S. Neelapu, Julio C. Chavez, Alison R. Sehgal, Narendranath Epperla, Matthew Ulrickson, Emmanuel Bachy, Pashna N. Munshi, Carla Casulo, David G. Maloney, Sven de Vos, Ran Reshef, Lori A. Leslie, Olalekan O. Oluwole, Ibrahim Yakoub-Agha, Rashmi Khanal, Joseph Rosenblatt, Ronald Korn, Weixin Peng, Christine Lui, Jacob Wulff, Rhine Shen, Soumya Poddar, A. Scott Jung, Harry Miao, Sara Beygi, Caron A. Jacobson
Journal: Blood
Blood (2024) 143 (6): 496–506.
https://doi.org/10.1182/blood.2023021243
Published: 2024
Includes: Supplemental data
Journal Articles

Defining Outcomes in Hispanic Aggressive Non-Hodgkin Lymphoma Patients.

Lara M Paraskos, M.D., Mariela A. Blum, MD, Maricer Escalon, MD, Annapoorna Ferrell, Erin Kobetz, Joseph Rosenblatt, MD
Journal: Blood
Blood (2009) 114 (22): 4542.
https://doi.org/10.1182/blood.V114.22.4542.4542
Published: 2009
Journal Articles

B Cell Depletion Reduces the Number and Function of T- Regulatory Cells and Enhances the Anti Tumor response

Tamar Tadmor, MD, Yu Zhang, MD, Robert Dunn, PHD, Seung-uon Shin, Hyung-Mee Cho, Joseph Rosenblatt, MD
Journal: Blood
Blood (2009) 114 (22): 3668.
https://doi.org/10.1182/blood.V114.22.3668.3668
Published: 2009
Journal Articles

The Antibody-Drug Conjugate Brentuximab Vedotin (SGN-35) Induced Multiple Objective Responses in Patients with Relapsed or Refractory CD30-Positive Lymphomas in a Phase 1 Weekly Dosing Study.

Michelle Fanale, MD, Nancy L Bartlett, MD, Andres Forero-Torres, MD, Joseph Rosenblatt, MD, Sandra J Horning, MD, Anna R Franklin, MD, Carmel M Lynch, PhD, Eric L Sievers, MD, Dana A Kennedy, PharmD, BCOP
Journal: Blood
Blood (2009) 114 (22): 2731.
https://doi.org/10.1182/blood.V114.22.2731.2731
Published: 2009
Journal Articles

High Remission Rates and Prolonged Progression Free Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma Treated with R-MACLOIVAM-T

Peter J Hosein, MD, Daniel Morgensztern, MD, Francine Coleman, MPH, Gail Walker, PhD, Maricer Escalon, MD, Joseph Rosenblatt, MD, Izidore S Lossos, MD
Journal: Blood
Blood (2008) 112 (11): 3597.
https://doi.org/10.1182/blood.V112.11.3597.3597
Published: 2008
Journal Articles

Phase-2 Study of R-MACLO-IVAM-T in Newly Diagnosed Mantle Cell Lymphoma.

Izidore S. Lossos, MD, Francine Colleman, Gail Walker, Maricer Escalon, MD, Joseph Rosenblatt, MD, Daniel Morgensztern, MD
Journal: Blood
Blood (2007) 110 (11): 1363.
https://doi.org/10.1182/blood.V110.11.1363.1363
Published: 2007
Journal Articles

SGN-30 (Anti-CD30 Monoclonal Antibody) Is Active and Well Tolerated in Patients with Refractory or Recurrent Systemic Anaplastic Large Cell Lymphoma.

Andres Forero-Torres, Steven Bernstein, Ajay Gopal, Francine Foss, John Leonard, Joseph Rosenblatt, Nancy Bartlett, Anas Younes, David Fisher, Bruce Cheson, Matthew Carabasi, Gregory Bociek, Bruce Hart, Michael McDonald
Journal: Blood
Blood (2004) 104 (11): 2637.
https://doi.org/10.1182/blood.V104.11.2637.2637
Published: 2004
Journal Articles

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial

Clinical Trials & Observations
Judith E. Karp, Jeffrey E. Lancet, Scott H. Kaufmann, David W. End, John J. Wright, Kees Bol, Ivan Horak, Michael L. Tidwell, Jane Liesveld, Timothy J. Kottke, Dawn Ange, Laxmi Buddharaju, Ivana Gojo, W. Edward Highsmith, Robert T. Belly, Raymond J. Hohl, Mary Ellen Rybak, Alain Thibault, Joseph Rosenblatt
Journal: Blood
Blood (2001) 97 (11): 3361–3369.
https://doi.org/10.1182/blood.V97.11.3361
Published: 2001